Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Chronic Male Pelvic Pain Syndrome
NCT00194623Phase 4Terminated
- Sponsor
- University of Washington
- Start
- Aug 2003
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, double-blind trial in chronic pelvic pain syndrome (CPPS) comparing Botox with Placebo (2 arms). Primary endpoint: National Institutes of Health Chronic Prostatitis Symptom Index at 3 months. Started Aug 2003; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
chronic pelvic pain syndrome (CPPS)
Beyond the preview
Go deeper on NCT00194623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00194623.